Lali Sekhon, MD, PhD. Spine Surgeon at Reno (Nev.) Orthopedic Center: "Flux," be it payments, indications, the role of enabling tech, etc. It's probably a good word for healthcare in general.
Angitia Biopharmaceuticals, a global, clinical-stage biotechnology company focused on the discovery and development of innovative therapeutics for serious musculoskeletal diseases, today announced ...